Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
+$588M |
| 2 |
Apple
AAPL
|
+$574M |
| 3 |
Illumina
ILMN
|
+$398M |
| 4 |
argenx
ARGX
|
+$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$600M |
| 2 |
AbbVie
ABBV
|
+$323M |
| 3 |
Sherwin-Williams
SHW
|
+$309M |
| 4 |
Atlassian
TEAM
|
+$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARTE
1576
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
| $1.1M | ﹤0.01% |
106,000
| – | – |
|
|
RXDX
1577
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.09M | ﹤0.01% |
10,203
+5,617
| +122% | +$603K |
|
1578
LGI Homes
LGIH
$1.41B
| $1.09M | ﹤0.01% |
9,583
+174
| +2% | +$19.8K |
|
1579
LivaNova
LIVN
$3.13B
| $1.09M | ﹤0.01% |
25,000
+15,098
| +152% | +$658K |
|
1580
Cal-Maine
CALM
$5.38B
| $1.09M | ﹤0.01% |
17,837
+9,005
| +102% | +$548K |
|
1581
Affirm
AFRM
$26.5B
| $1.09M | ﹤0.01% |
+96,286
| New | +$1.09M |
|
|
EQC
1582
DELISTED
Equity Commonwealth
EQC
| $1.08M | ﹤0.01% |
52,275
+30,556
| +141% | +$633K |
|
1583
Transmedics
TMDX
$3.99B
| $1.08M | ﹤0.01% |
14,234
+9,217
| +184% | +$698K |
|
1584
Annaly Capital Management
NLY
$14.2B
| $1.08M | ﹤0.01% |
56,330
+505
| +0.9% | +$9.65K |
|
1585
WD-40
WDFC
$2.85B
| $1.08M | ﹤0.01% |
6,050
+3,270
| +118% | +$582K |
|
|
PDCO
1586
DELISTED
Patterson Companies, Inc.
PDCO
| $1.07M | ﹤0.01% |
40,105
+20,964
| +110% | +$561K |
|
1587
Acushnet Holdings
GOLF
$4.37B
| $1.07M | ﹤0.01% |
21,066
+6,206
| +42% | +$316K |
|
1588
Macerich
MAC
$4.61B
| $1.07M | ﹤0.01% |
101,015
+59,681
| +144% | +$632K |
|
|
RCM
1589
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.07M | ﹤0.01% |
70,978
+46,101
| +185% | +$692K |
|
1590
Surgery Partners
SGRY
$2.75B
| $1.06M | ﹤0.01% |
30,907
+16,182
| +110% | +$558K |
|
|
AMED
1591
DELISTED
Amedisys
AMED
| $1.06M | ﹤0.01% |
14,437
-6,840
| -32% | -$503K |
|
1592
Universal Health Services
UHS
$11.8B
| $1.06M | ﹤0.01% |
8,354
+2,653
| +47% | +$337K |
|
1593
Kontoor Brands
KTB
$4.67B
| $1.06M | ﹤0.01% |
21,900
+11,979
| +121% | +$580K |
|
1594
Southwest Airlines
LUV
$16.3B
| $1.05M | ﹤0.01% |
32,408
+15,217
| +89% | +$495K |
|
1595
EQT Corp
EQT
$31.8B
| $1.05M | ﹤0.01% |
33,041
+11,265
| +52% | +$360K |
|
|
BPMC
1596
DELISTED
Blueprint Medicines
BPMC
| $1.05M | ﹤0.01% |
23,431
+12,221
| +109% | +$549K |
|
|
WEL
1597
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $1.05M | ﹤0.01% |
100,000
| – | – |
|
1598
CVB Financial
CVBF
$2.8B
| $1.05M | ﹤0.01% |
63,100
+36,900
| +141% | +$615K |
|
1599
Materion
MTRN
$2.29B
| $1.05M | ﹤0.01% |
9,061
+4,932
| +119% | +$572K |
|
1600
Alarm.com
ALRM
$2.76B
| $1.05M | ﹤0.01% |
20,892
-39,358
| -65% | -$1.98M |
|